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ABSTRACT 
Vascular anomalies well-known as birthmarks are benign lesions of blood vessels or vascular elements are often considered 
errors of vascular morphogenesis. Numerous terms have been used to describe vascular anomalies on the basis of physical 
appearances leading to misdiagnosis followed by complications in the management of the lesion. Lack of complete 
understanding of the anomaly result in misdiagnosis. Main aim of this paper is to discuss the vascular anomalies of the head 
and neck region in detail which will enable the dental practitioner to arrive at a better diagnosis. 
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rom being a good luck charm to the kiss of an angel 
bestowed by the heavenly stars, these marks of life 
are sometimes the cause of disfigurement. Be it 
clusters of veins, arteries or lymph channels, often give 
rise to these marks which are noticed within or under the 
skin as soft mass or stain that are compressible, non-
pulsating with bluish-red tinge. They differ from each 
other in having different clinical, histological and imaging 
features and hence differ in management protocols. 
Although painless, these lesions can result in significant 
cosmetic disfigurements and lead to life threatening 
hemorrhages after a simple surgical procedure such as 
extraction.  
Due to the usage of perplexing colloquial terms based 
only on clinical outlook, practitioner often misdiagnoses 
the anomaly which will bring about reduced outcome of 
treatment advised. Therefore thorough knowledge and 
understanding of each type of vascular anomaly plays an 
eminent role in the diagnosis. In this review we discuss 
about the newer terminologies, current classification, 
pathogenesis, salient clinical and immunohistochemical 
features of individual anomaly, different imaging 
modalities used and the management of lesion so as to 
avoid further bewilderment in diagnosis and treatment 
protocol. 
Classification 
Vascular anomalies are either congenital or appear 
within first year of life [1]. These are benign lesions which 
can appear anywhere in the body but often evident in the 
head and neck region with 5-10% prevalence rates [2, 3]. 
Dormant lesion can be triggered by certain factors such as 
trauma, infection, hormonal alterations and progressive 
increase in age. 
 
Abnormal vascular morphogenesis, 
increased mitotic activity as well as cellular 
hyperproliferation are thought to play a role in its 
pathogenesis [1, 4]. Several classifications have been put 
forward to categorize these lesions. In 1982, Mulliken and 
Glowacki classified the vascular anomalies based on the 
endothelial cells and clinical characteristics into vascular 
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tumors and vascular malformations. In 1996, the 
International Society for the Study of Vascular Anomalies  
 
(ISSVA) used fundamentals of Mulliken and Glowacki’s 
classification system along with immunohistochemical 
aspects. In 1999, Waner and Suen modified the ISSVA 
classification to clinically useful classification system [1-
6]. (Table 1) 
Table 1: classification of vascular anomalies [1]
 
 
 
 
Vascular Tumors 
 
Infantile hemangiomas 
Congenital hemangiomas (RICH, NICH) 
Tufted angioma (with or without Kasabah-Meritt Syndrome) 
Kaposiform hemangioendothelioma (with or without Kasabah-Meritt Syndrome) 
Spindle cell hemangioendothelioma 
Dermatologic acquired vascular tumors (Pyogenic granuloma, targeoid hemangioma, 
glomeruloid hemangioma, microvenular hemangioma, etc) 
 
 
 
 
 
 
 
Vascular 
Malformations 
 
 
 
 
 
Slow-flow vascular 
malformations 
 
 
Capillary malformations 
(CM) 
 
Port-wine stain 
Telengiectasia 
Angiokeratoma 
 
 
 
Venous malformation (VM) 
 
Common sporadic VM 
Bean syndrome 
Familial cutaneous and mucosal 
venous malformation(VMCM) 
Glomuvenous malformation(GVM) 
Mafucci syndrome 
Lympatic malformation (LM) 
 
 
 
Fast-flow malformations 
 
Arterial malformation (AM) 
Arteriovenous fistula (AVF) 
Arteriovenous malformation (AVM) 
Complex-combined vascular 
malformations 
 
 
CVM,CLM,LVM,CLVM,AVM-LM,CM-AVM 
 
VASCULAR TUMORS: 
Hemangioma: 
Hemangiomas are the most commonly occurring tumor 
in infants mostly in females with incidence of 10% [1, 4, 
7]. People with light colored skin, premature birth and low 
birth weight are considered to be at higher risk. 
Hemangiomas generally occur sporadically however, may 
perhaps be familial expressed as autosomal dominant 
inheritance pattern, with loss of heterozygosity on 
chromosome 5q31-33.5 comprising of rapidly dividing 
endothelial cells [8, 9]. 
Pathogenesis has been put forward based on following 
two theories: First theory suggests, disrupted placental 
tissue give rise to hemangiomas endothelial cells which is 
found embedded in fetal soft tissue during gestation/birth. 
The tissue specific markers are: GLUT-1, CD14 (Lewis 
antigen) CD32 (FcGammaR2) and Merosin [10,11].  
 
Second theory evolved on sighting the endothelial 
progenitor and stem cells in the circulation of patients with 
hemangiomas. Abnormal levels of MMP-9 and 
proangiogenic factors (VEGF, b-FGF and TGF-β1) play a 
role in pathogenesis [12]. 
When hemangiomas are visualized in utero and 
perceived at birth they are termed as congenital 
hemangiomas (CH) having 20% incidence rates. They do 
not proliferate after birth. Based on the involution they are 
subcategorized as Rapidly Involuting Congenital 
Hemangiomas (RICH) And Non- Involuting Congenital 
Hemangiomas (NICH). Infantile hemangiomas (IH) 
present shortly after birth [13-15]. Hemangiomas manifest 
in 3 developmental phases: proliferation- rapid growth 
phase lasts for 3 months of life. Followed by a slow or no 
growth phase termed quiescence, lasts from 9-12 months. 
Finally there is graying of overlying skin and deeper 
component shrinking knows as involution phase [16]. 
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Superficial Hemangiomas are red, nodular with no 
subcutaneous component. Whereas, Deep hemangiomas 
have bluish tinge or telangectasia. Compound hemangioma 
consists of superficial and deep components. Focal 
Hemangiomas are localized, unilocular lesions while, 
segmental hemangiomas are diffuse plaque-like. If 
multifocal hemangiomas present with lesions >5 in 
number examination of visceral organs is recommended to 
rule out syndromes associated like, PHACE and 
LUMBAR syndrome [17].  
Diagnosis is best made by history and physical 
examination.MRI with contrast or Doppler Ultrasound is 
used to confirm the diagnosis [18-20]. Currently 
established treatment ideology is “close observation” 
reinstated traditional “watch and wait” method with 
following approaches i.e., accurate diagnosis, early 
management of complications, decrease in complications 
and increased morale with positive psychological state 
[21]. Medical management includes first line steroid 
therapy, lasers, bleomycin a5 is an effective substitute for 
vincristine and interferon resistant hemangiomas. Surgical 
resection is considered in cases of accessible hemangiomas 
[22-24].  
Tufted Angioma (TA) and Kaposiform 
Hemangioendothelioma (KH) 
Being presented as vascular tufts of capillaries (TA) 
and components of vascular and lymphatic channel (KH), 
these rare vasoproliferative tumors display at or shortly 
after birth. They are sometimes associated with secondary 
destructive osseous changes. A syndrome associated with 
is Kasabach-Meritt syndrome.
 
Immunostaining patterns of 
monoclonal antibodyD2-40 help to differentiate TA from 
KH.
 
Imaging modalities are same as vasoproliferative 
neoplasms. Management is similar to those for infantile 
hemangioma. When there is aggressive local behavior 
wide local excision and supportive treatment the mainstay 
of therapy [25, 26]. 
 
Hemangioendothelioma  
Being considered a benign reactive vasoproliferation 
that present at any age throughout the body, was first 
described in 1986 as a rare vascular neoplasm. 
Immunohistochemistry is positive for CD31 and factor 
VIII antigen and negative for CD34 [5]. Epithelial 
hemangioendothelioma is rare, slowly progressive, distinct 
pathological tumors occur anywhere in the body. Most 
common in the skeleton and is an accidental finding during 
normal investigative procedures. Other rare types of 
hemangioendotheliomas are Composite, Retiform, 
Polymorphous, Dabska Tumor and 
Lymphangioendotheliomas. Dermatologically acquired 
vascular tumors include Pyogenic Granuloma, Targeoid 
Hemangioma, Glomeruloid Hemangioma, Microvenular 
Hemangioma etc [18,19].
 
Angiosarcoma: 
Is a rare aggressive neoplasm, has female 
predominance and average age of onset is 3.7 years. Cross 
sectional imaging shows an aggressive heterogenous mass 
with pooling of contrast and multiple synchronous or 
metastatic lesions in the liver [5, 13].  
VASCULAR MALFORMATIONS: 
Vascular malformations are congenital morphogenic 
anomalies composed of inappropriately connected 
vasculature. Lesions infiltrate normal tissues, do not 
regress and continue to expand with time. They can be 
subdivided into 2 categories, slow/low flow consists of 
combinations of capillary, venous and lymphatic 
components and fast/high flow malformations contain 
arterial component in combination with other vascular 
structures [2,4,19]. 
 
Slow flow malformations:  
Venous malformations: 
Previously known as “venous angioma” and 
“cavernous hemangiomas”, these are most commonly seen 
vascular malformations. They are generally sporadic, 
sometimes familial with association of chromosome 9p 
[18,27]. Studies show loss of function mutation on 
angiopoetin receptor gene TIE2/TEK, and up regulation of 
TGF-β and β-FGF factors as well as presence of 
progesterone receptors.
 
 
Often congenital, these consist of abnormally formed 
and dilated superficial or deep veins, with thin walls due to 
lack of smooth muscle and appear as a bluish patch/mark. 
VM can be localized/generalized and can occur anywhere 
in the body which are compressible and swell with 
increased hydrostatic pressure. Elevated D-dimers is 
marker of the disease [4]. They can be found 
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intraossseously which differentiates it from hemangioma. 
Complications could be pain, swelling with formation of 
phleboliths and coagulopathies. MRI is most useful 
diagnostic. Treatment includes sclerotherapy with ethanol 
and sotradecol, laser therapy (ND: YAG, PDL, Gentile 
YAG or KTP) and surgery [27-29].  
Capillary malformations: 
Hemodynamically inactive superficial sporadic lesions 
affecting the skin and/or mucosal capillary network are 
found anywhere in the body, mostly in cervicofacial region 
[1]. They can be categorized into medial form consisting 
of stork bites on nape of the neck, angel kisses on forehead 
which gradually lighten with time and disappear [30]. 
Lateral forms commonly known as port wine stains. Other 
examples of CM’s are nevus flammeus, telangectasias, and 
spider nevus. 
 
Pathogenesis is indefinite. Genome wide linkage 
analysis has identified a locus on chromosome 5q 
association with disease [4]. Congenital CM’s are flat, red 
or purple patches with irregular borders. Port wine stains 
are usually seen along the distribution of trigeminal nerve. 
Lesions progress with time and become darker, elevated 
and nodular. Diagnosis is by physical examination. In case 
of associated symptoms MRI may be performed. FDPL 
Laser is the main treatment modality. Surgical excision is 
an option in lesions amenable to lasers [31-33]. 
 
Lymphatic malformations: 
LM’s are sporadic lesions composed of lymphatic 
vessels with inappropriate communications, lined by 
endothelial cells and filled with lymphatic fluid. Earlier 
known as “cystic hygroma” and lymphangioma” terms are 
no longer used. They are mostly congenital or appear by 2 
years of life, are non-tender and soft can occur in any part 
of the body. Local infections may cause LM to swell, 
protrude and become painful. They can be classified as, 
Macrocystic (>2cm
3
) which are present beneath the skin, 
Microcystic (2cm
3<
) have small vesicles over the swelling 
involving skin or mucosa and Mixed [2]. 
Etiology is unclear. Receptors involved in the 
formation of lymphatic vascular channels like, VEGFR3 
and Prox-1 may play a role in development of disease. LM 
can also occur as a result of trauma or infection. 
Complications include dysphagia, odynophagia, impaired 
speech, severe obstruction. Involvement of skeletal 
framework can cause osseous dystrophy leading to dental 
or extremity abnormalities [34]. Diagnosis is based on 
clinical presentation and imaging modalities like MRI, 
Ultrasonography and Doppler. Treatment modalities for 
larger lesions include aspiration of contents followed by 
injection of sclerosing agent. Laser ablation and surgical 
treatment could also be used. NdYAG and diode laser 
photocoagulation can be used to treat microcystic LM [35]. 
 
High flow vascular malformations: 
Arteriovenous Malformation and Arterovenous 
Fistula: 
AVM and AVF are congenital and acquired 
malformations respectively.
 
They are hemodynamically 
active malformations with rapid flow consist of capillary 
beds shunting blood from arterial system to the venous 
system. AVM consist of the core (nidus), multiple feeding 
arteries and widened draining veins which are pulsatile, 
either superficial or deep [5,36]. Whereas AVF lacks the 
nidus. Even though they are present at birth, they are not 
detected until puberty, sometimes lesion presents after 
trauma. A defect in vascular stabilization is thought to be 
the cause of these malformations. Defects in TGF-beta 
signaling and a genetic two-hit hypothesis theories help 
explain the pathogenesis. Expansion in puberty is due to 
the presence of progesterone receptors [37]. The 
characteristic features will be palpable warmth, pulse, or 
thrill due to high vascular flow. Common locations are 
intracranial, intraosseous and subcutaneous fat. They are 
infiltrative causing destruction of local tissues and are life 
threatening secondary to massive bleeding. They can be 
associated with hereditary hemorrhagic telangiectasia 
syndrome [5].
 
Imaging is mainstay in diagnosing the extent of AVM 
and AVF which includes, MRI, MRS, CTA and color 
Doppler ultrasound. Angiography should precede the 
treatment for complete mapping of the vessels. 
Endovascular embolization and surgical resection are main 
treatment modalities which includes palliative, 
complication control and curative as major protocols. 
Treatment of AVM is challenging because of high 
recurrence rate [1,4,37,38].  
CONCLUSION 
Though vascular anomalies do not bring about any 
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functional oriented problems, it does pose a source of 
psychological stigma to the patient and their families. 
Approach in management of such anomalies differs from 
lesion to lesion. Identifying the anomaly with proper 
nomenclature is the utmost importance in the diagnosis. 
Lesion can be diagnosed on basis of physical examination, 
histochemical markers and other imaging modalities. 
Treatment of vascular anomalies is complex and involves 
multidisciplinary approach to prevent further 
complications and rendering a positive psychological 
approach   to patients. 
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